Europe Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook

The clinical trial biorepository & archiving solutions market in Europe is expected to reach a projected revenue of US$ 2,315.1 million by 2030. A compound annual growth rate of 7% is expected of Europe clinical trial biorepository & archiving solutions market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,445.5
Forecast, 2030 (US$M)
$2,315.1
CAGR, 2024 - 2030
7%
Report Coverage
Europe

Europe clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)

Europe

Related Markets

Europe clinical trial biorepository & archiving solutions market highlights

  • The Europe clinical trial biorepository & archiving solutions market generated a revenue of USD 1,445.5 million in 2023.
  • The market is expected to grow at a CAGR of 7% from 2024 to 2030.
  • In terms of segment, biorepository services was the largest revenue generating service in 2023.
  • Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 1,445.5 million
Market revenue in 2030USD 2,315.1 million
Growth rate7% (CAGR from 2023 to 2030)
Largest segmentBiorepository services
Fastest growing segmentBiorepository Services
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiorepository Services, Archiving Solution Services
Key market players worldwideAzenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 36.0% of the global clinical trial biorepository & archiving solutions market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,211.9 million by 2030.

Biorepository services was the largest segment with a revenue share of 66.35% in 2023. Horizon Databook has segmented the Europe clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.


Europe is one of the leading markets for clinical trial biorepository & archiving solutions owing to advancements in technology, increasing number of clinical trials in this region, and presence of key players offering clinical trial biorepository & archiving solutions. For instance, in November 2020, Avantor established a new biorepository facility in Europe to meet the rising demand for clinical trial sample storage and research.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Biorepository & Archiving Solutions Market Companies

Name Profile # Employees HQ Website

Europe clinical trial biorepository & archiving solutions market size, by country, 2018-2030 (US$M)

Europe Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2023 & 2030 (US$M)

Europe clinical trial biorepository & archiving solutions market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more